Oversight of the new drug review process and FDA's regulation of Merital [microform] : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986

Request this item

Request this item to view in the Library’s reading room.

Loading...